Reshma A. Rangwala
Impact in
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 20
- Cancer Immunotherapy and Biomarkers 14
- HER2/EGFR in Cancer Research 5
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Rina Hui (7 shared papers)Gregory M. Lubiniecki (6 shared papers)Delvys Rodríguez‐Abreu (6 shared papers)Maya Gottfried (6 shared papers)Tibor Csőszi (5 shared papers)Suman Rao (5 shared papers)Julie Renee Brahmer (6 shared papers)Nir Peled (5 shared papers)
- Journals
- Annals of Oncology (5 papers)Journal of Thoracic Oncology (4 papers)The Lancet Oncology (3 papers)Autophagy (3 papers)Gynecologic Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Reshma A. Rangwala
32 papers receiving 16.4k citations
Reshma A. Rangwala's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 10.6k
- Pulmonary and Respiratory Medicine 4.6k
- Immunology 3.1k
- Cancer Research 1.4k
- Obstetrics and Gynecology 317
Countries citing papers authored by Reshma A. Rangwala
This map shows the geographic impact of Reshma A. Rangwala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reshma A. Rangwala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reshma A. Rangwala more than expected).
Fields of papers citing papers by Reshma A. Rangwala
This network shows the impact of papers produced by Reshma A. Rangwala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reshma A. Rangwala. The network helps show where Reshma A. Rangwala may publish in the future.
Co-authors
The 25 scholars most cited alongside Reshma A. Rangwala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer Hit paper breakdown → | 2016 | 8178 |
| 2 | Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer Hit paper breakdown → | 2015 | 5263 |
| 3 | Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial Hit paper breakdown → | 2017 | 437 |
| 4 | 2014 | 373 | |
| 5 | 2014 | 337 | |
| 6 | Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study Hit paper breakdown → | 2021 | 324 |
| 7 | 2014 | 319 | |
| 8 | 2017 | 290 | |
| 9 | 2019 | 204 | |
| 10 | 2017 | 203 | |
| 11 | 2005 | 142 | |
| 12 | 2019 | 113 | |
| 13 | 2002 | 70 | |
| 14 | 2005 | 59 | |
| 15 | 2002 | 56 | |
| 16 | 2016 | 54 | |
| 17 | 2023 | 46 | |
| 18 | 2002 | 36 | |
| 19 | 2021 | 28 | |
| 20 | 2016 | 15 |
About Reshma A. Rangwala
Reshma A. Rangwala is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Immunology and Allergy and Obstetrics and Gynecology, having authored 32 papers that have together received 16.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (6 papers), HER2/EGFR in Cancer Research (5 papers), Autophagy in Disease and Therapy (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Phagocytosis and Immune Regulation (2 papers), Glycosylation and Glycoproteins Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (10.6k citations), Pulmonary and Respiratory Medicine (4.6k citations), Immunology (3.1k citations), Cancer Research (1.4k citations) and Obstetrics and Gynecology (317 citations). Reshma A. Rangwala has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Rina Hui, Gregory M. Lubiniecki, Delvys Rodríguez‐Abreu, Maya Gottfried, Tibor Csőszi, Suman Rao, Julie Renee Brahmer, Nir Peled, Mary E.R. O'Brien and Andrew George Robinson. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, The Lancet Oncology, Autophagy and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.